Related references
Note: Only part of the references are listed.Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis
Divyanshu Dubey et al.
CURRENT OPINION IN NEUROLOGY (2016)
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats
Ruihe Lin et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier
Jamie L. Lim et al.
MICROVASCULAR RESEARCH (2016)
PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?
Klaus Lehmann-Horn et al.
NEUROLOGY (2016)
More on PML in Patients Treated with Dimethyl Fumarate
Kristian Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
CD8+ T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing
Tilman Schneider-Hohendorf et al.
NATURE COMMUNICATIONS (2016)
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
Catharina C. Gross et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi et al.
ACTA NEUROPATHOLOGICA (2015)
PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate
Dennis J. Nieuwkamp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
Thorsten Rosenkranz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk
Bhupendra O. Khatri et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
How leukocytes cross the vascular endothelium
Dietmar Vestweber
NATURE REVIEWS IMMUNOLOGY (2015)
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models
Yasuyuki Kihara et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Ultraviolet B Light Attenuates the Systemic Immune Response in Central Nervous System Autoimmunity
Johanna Breuer et al.
ANNALS OF NEUROLOGY (2014)
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE
Hui Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
Tilman Schneider-Hohendorf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
Bob W. van Oosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PML in a Patient Treated with Fumaric Acid
Ummehan Ermis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Fatal PML associated with efalizumab therapy Insights into integrin αLβ2 in JC virus control
N. Schwab et al.
NEUROLOGY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions
Katrin Wallbrecht et al.
EXPERIMENTAL DERMATOLOGY (2011)
Natalizumab treatment reduces endothelial activity in MS patients
Alban Millonig et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Roles of the NF-κB Pathway in Lymphocyte Development and Function
Steve Gerondakis et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
Mustafa Zakkar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression
Simone A. Rubant et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium
Dietmar Vestweber
IMMUNOLOGICAL REVIEWS (2007)
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression
XL Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
NF-κB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression
A Banning et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Share Paper
